Karel Geboes

Researcher Next ID · RN-039758

Researcher · Biochemistry, Genetics and Molecular Biology

Ghent, Belgium

Accepting doctoral researchersFunding unknown

Research interests

Biochemistry, Genetics and Molecular Biology

Medicine

Inflammatory Bowel Disease

Microscopic Colitis

Autoimmune and Inflammatory Disorders

Retinal Diseases and Treatments

Helicobacter pylori-related gastroenterology studies

Prognostic Value of Serologic and Histologic Markers on Clinical Relapse in Ulcerative Colitis Patients With Mucosal Healing
The American Journal of Gastroenterology · 2012 · https://doi.org/10.1038/ajg.2012.301
Adalimumab Induces and Maintains Mucosal Healing in Patients With Crohn's Disease: Data From the EXTEND Trial
Gastroenterology · 2012 · https://doi.org/10.1053/j.gastro.2012.01.035
Mucosal gene signatures to predict response to infliximab in patients with ulcerative colitis
Gut · 2009 · https://doi.org/10.1136/gut.2009.178665
Ornidazole for prophylaxis of postoperative Crohn’s disease recurrence: A randomized, double-blind, placebo-controlled trial
Gastroenterology · 2005 · https://doi.org/10.1053/j.gastro.2005.01.010
Anti-tumor necrosis factor treatment restores the gut barrier in Crohn's disease
The American Journal of Gastroenterology · 2002 · https://doi.org/10.1111/j.1572-0241.2002.05914.x
Tumor necrosis factor α antibody (infliximab) therapy profoundly down-regulates the inflammation in Crohn's ileocolitis
Gastroenterology · 1999 · https://doi.org/10.1016/s0016-5085(99)70224-6

No projects listed.